Loading
Life sciences · Interventional Study
ClinicalTrials.gov · October 5, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Interventional Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07858318). This is a study registration, not published results. Lead sponsor: Washington University School of Medicine. Recruitment status: NOT_YET_RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 20 participants (ESTIMATED). Conditions: Cardiac Rehabilitation, Heart Failure. Interventions: OTHER: Early Referral; OTHER: Standard Of Care (SOC) + Placebo. Primary outcome measures: Safety and Tolerability of Accelerated ICR 2 weeks and 6 weeks post-hospital discharge , From enrollment, to completion of at least 24 cardiac rehabilitation days.. Brief summary: The purpose of this study is to see if patients undergoing accelerated Intensive Cardiac Rehabilitation (ICR) (2 weeks after discharge) will improve exercise performance as well as on measures of quality of life after a cardiac hospitalization.